Tuesday, March 18, 2025 | 07:17 AM ISTहिंदी में पढें
Business Standard
Notification Icon
userprofile IconSearch

Zydus Cadila receives USFDA final approval for Valsartan and Hydrochlorothiazide Tablets

Image

Capital Market
Zydus Cadila has received the final approval from the USFDA to market Valsartan and Hydrochlorothiazide Tablets USP (US RLD Diovan HCT Tablets) in the strengths of 80 mg/12.5 mg, 160 mtg/12.5 mg, 160 mg/25 mg, 320 mtg/12.5 mg, and 320 mg/25 mg. The drug is used to treat high blood pressure. Lowering high blood pressure helps prevent strokes, heart attacks and kidney problems. It will be manufactured at the group's formulations manufacturing facility at Moraiya, Ahmedabad.

Powered by Capital Market - Live News

Disclaimer: No Business Standard Journalist was involved in creation of this content

Don't miss the most important news and views of the day. Get them on our Telegram channel

First Published: Mar 16 2019 | 1:23 PM IST

Explore News